Ownership Summary
Perspective Therapeutics, Inc. (NYSE:CATX) has 2 institutional investors that have filed 13F reports for the period ending December 2025.
- Their combined ownership stood at 0.3% of outstanding shares in December 2025, down from 1.6% in September 2025.
- Their total shares held in CATX decreased -79.5% quarter over quarter, and separately, investors owning Perspective Therapeutics increased 100.0% from a year ago.
- Of these 2 holders, 0 added to their stakes in Perspective Therapeutics, 1 trimmed positions, and 1 made no changes.
- Institutional investors collectively held 250.5K shares in Perspective Therapeutics as of December 2025, down by 971.47K shares quarter on quarter, and up 100.5K shares year over year.
- As of December 31, 2025, PORTLAND INVESTMENT COUNSEL INC. held the largest stake in Perspective Therapeutics with 250.0K shares, accounting for 0.34% of total shares outstanding.
- The biggest sellers of Perspective Therapeutics for the quarter ending December 2025 included VESTOR CAPITAL, LLC (971.47K).
- Business Quant data shows the 2 biggest positions in Perspective Therapeutics as of December 2025 are held by PORTLAND INVESTMENT COUNSEL INC. (250.0K), VESTOR CAPITAL, LLC (502).